The Feasibility of Hybrid IMRT treatment planning for Left sided Chest wall irradiation: A Comparative Treatment Planning Study

Document Type : Original Paper


1 Department of Physics, Institute of Applied Science and Humanities, GLA University, Mathura-281406(U.P.), India. Department of Radiotherapy, Saroj Gupta Cancer Centre and Research Institute, Kolkata- 700063(W.B), India.

2 Department of Radiotherapy, Alexis Multispecialty Hospital, Nagpur -440030, Maharashtra.

3 Department of Mathematics, Institute of Applied Science and Humanities, GLA University, Mathura-281406(U.P.), India.

4 Department of Radiotherapy, Apollo Multispeciality Hospital, Canal Circular Road, Kolkata-700 054(W.B), India.

5 Department of Radiotherapy, Gandhi Medical College, Bhopal- 462001 (M.P.), India.


Introduction: Due to the limited target volume and irregular body surface, irradiating the chest wall (CW) and lymphatic nodes is more challenging. IMRT and VMAT (volumetric modulated arc therapy) are two treatment delivery techniques that help to improve dose coverage and homogeneity while reducing irradiation to the heart and ipsilateral (I/L) lung. The use of a hybrid treatment planning approach for the ca-breast will impact the treatment plan. The hybrid planning system must be reviewed and compared to alternative treatment options for ca-breast cancer.
Material and Methods: For 10 patients undergoing left-sided breast chest wall irradiation, the 3 distinct planning techniques (FiF [Field-in-field], IMRT, and Hybrid IMRT) were evaluated. A prescription dose of 40 Gy in 15 fractions was used for the planned target volume (PTV). To compare plans, dose-volume histograms (DVHs) were assessed for PTV and organs at risk.
Results: D95% of PTV was 37.10 ± 0.48 Gy in FiF, but considerably raised to 39.32 ± 0.34 Gy and 38.39 ± 0.29 Gy in IMRT (p=0.01) and Hybrid IMRT (p=0.01).When compared to IMRT (0.981 ± 0.014) and Hybrid IMRT (0.970 ± 0.013) FiF plans have the lowest CI value of 0.931 ± 0.026. IMRT plans (0.087 ± 0.021) were found to be more homogeneous than other 2 planning techniques (0.111 ± 0.013 [FiF, p=0.016], 0.107 ± 0.021[hybrid IMRT, p=0.056]).
Conclusion: Hybrid IMRT treatment plans for the ca-breast are recommended because they provide superior and similar PTV dose coverage and OAR sparing compared to FiF and IMRT plans. Hybrid IMRT plans feature lower MU and BOT, as well as a smaller low dose volume in comparison to IMRT.


Main Subjects

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 V1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from
  2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212–
  3. Kuraparthy S, Reddy KM, Yadagiri LA, Mutheeswaraiah Yutla,Phanindra BV,Sarma VS, et al. Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. World J Surg Oncol. 2007; 5:56.
  4. McGale P, Taylor C, Correa C, Cutter D, Duane F. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127-35
  5. Balaji K, Subramanian B, Yadav P, Anuradha C, Velayudham R. Radiation therapy for breast cancer: literature review .Med Dosim. 2016 ;41:257 .
  6. Darby SC, Ewertz M, McGale P,Bennet A, Goldman U,Cutter D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368: 987–
  7. Schubert LK, Gondi V, Sengbusch E, Westerly DC, Soisson ET, Paliwal BR, et al : Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol. 2011; 100: 241-6.
  8. Kelly CA, Wang XY, Chu JC, Hartsell WF. Dose to contralateral breast: a comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys. 1996; 34: 727-32.
  9. Unnithan J and Macklis RM: Contralateral breast cancer risk. Radiother Oncol. 2001; 60: 239-46.
  10. Smith BD, Pan IW, Shih YC. Adoption of intensity‑modulated radiation therapy for breast cancer in the United States. J Nat Cancer Inst. 2011; 103: 798‑809.
  11. Selvaraj RN, Beriwal S, Pourarian RJ. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer. Med Dosim. 2007; 32: 299‑304.
  12. Guerrero M, Li XA, Earl MA, Sarfaraz M, Kiggundu E. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys. 2004; 59: 1513‑22.
  13. Haciislamoglu E, Colak F, Canyilmaz E, Zengin AY, Yilmaz AH, Yoney A. the Choice of Multi-Beam IMRT for Whole Breast Radiotherapy in Early-Stage Right Breast Cancer. Springer Plus. 2016;28:5(1):688.
  14. Kachnic LA, Powell SN. IMRT for breast cancer - balancing outcomes, patient selection, and resource utilization. J Natl Cancer Inst. 2011; 18:103(10):777-9
  15. Charles S., Urie MM, Fitzgerald TJ. Hybrid IMRT plans-concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys. 2005; 61:922–
  16. Farace P, Zucca S, Solla I, Fadda G, Durzu S, Porru S, et al. planning hybrid intensity modulated radiation therapy for whole-breast irradiation. Int J Radiat Oncol Biol Phys 2012; 84(1):115–
  17. Yao W. A two-point scheme for optimal breast IMRT treatment planning. J Appl Clin Med Phys. 2013; 14:307–
  18. Shiau AC, Hsieh CH, Tien HJ, Yeh HP, Lin CT, Shueng PW, et al. Left-sided whole breast irradiation with hybrid-IMRT and  helical tomotherapy dosimetric comparison. BioMed Res Int. 2014; 2014:741326.
  19. Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). ICRU Report 83. Journal of ICRU. 2010; 10(1).
  20. Chen YG, Li AC, Li WY, Huang MY, Li XB, Chen MQ, et al. The feasibility study of a hybrid coplanar arc technique versus hybrid intensity-modulated radiotherapy in treatment of early-stage left-sided breast cancer with simultaneous-integrated boost. J Med Phys. 2017; 42(1):1–
  21. Johansen S, Cozzi L, Olsen DR. A planning comparison of dose patterns in organ at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and Volumetric modulated arc treatment techniques. Acta Oncol. 2009; 48:495-503.
  22. Qiao L, Xie J, Cheng J. Dosimetric comparison to organs at risk sparing using volumetric-modulated arc therapy versus intensity-modulated radiotherapy of left-sided breast cancer. Med Phys. 2015; 42:3238.
  23. Xu H, Hatcher G. Treatment planning study of volumetric modulated arc therapy for left-sided breast and chest wall cancer. Med Phys. 2014; 41:337.
  24. Xie X, Ouyang S, Wang H, Yang W, Jin H, Hu B, et al Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT. Oncol Rep. 2014; 31:2195–
  25. Jeulink M, Dahele M, Meijnen P. Is there a preferred IMRT technique for left-breast irradiation? J Appl Clin Med Phys. 2015; 16:197–
  26. Lin J, Yeh D, Yeh H. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy and intensity- modulated radiation therapy for left-sided early breast cancer.Med Dosim. 2015;40:262-7.
  27. Virén T, Heikkilä J, Myllyoja K. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiat Oncol. 2015 8; 10:79.
  28. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registers. Lancet Oncol. 2005; 6:557–
  29. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Ho lowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in surveillance, epidemiology, and end-results cancer registers. J Clin Oncol. 1998; 16:2625–
  30. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women dafter radiotherapy for breast cancer. N Eng J Med. 2013; 368: 987–
  31. Henson K E, McGale P, Taylor  C, Darby SC. Radiation related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br Jcancer. 2013; 108: 179–
  32. Stovall M, Smith SA, Langholz BM, Boice JD Jr., Shore RE, Andersson M. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008; 72:1021‑30.
  33. Hall EJ, Wuu CS. Radiation‑induced second cancers: The impact of 3D‑CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003; 56:83‑8.
  34. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity‑modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005; 62:1195‑203.